APPII, the UK-based digital verification technology company, has today announced its partnership with McKesson Group’s MASTA, (Medical Advisory Services for Travellers Abroad), and Coforge to launch the first-of-its-kind, fully integrated, end-to-end, digitally verified COVID-19 test, underpinned by EMIS technology.

From today (Tuesday 09 March), APPII customers can book, pay for and store COVID-19 PCR tests results. Tests can be booked at eight MASTA travel clinics nationally, with the service due to expand to over 200 LloydsPharmacys UK-wide branches over the coming weeks.

Individual test results and QR code certificates are verified and safely stored in the APPII mobile app, iiPass, ensuring customers have secure, digital access to results. The QR code results can then be scanned by organisations to determine the individual’s test status and whether iiPass users can continue with their desired activity, paving the way to safely unlock the UK economy.

iiPass also provides unique fraud prevention assurance compared to self-attestation services on the market. Users can conveniently upload a selfie and photo of an identity document (passport or drivers’ licence) which is processed by leading biometric identity provider GBG plc.

How does it work?

Highly accurate PCR test - As the chosen UK provider of COVID-19 tests and verification for international travel and trusted partners of the NHS, John Lewis partnership, and the Foreign Common Office, MASTA carries out a highly accurate PCR test, with results made available for iiPass users in the app.

Advanced anti-fraud capability - Verification of an individual’s identity is key to ensuring the validity of health data. By using biometric identity verification that uses data from an approved and accredited source, iiPass is the UK’s safest and most secure COVID-19 test recording system with the guarantee that results are valid and tamper-proof as they are automatically compared within the app.

Simple-to-use, convenient digital verification - By upgrading to the iiPass app, MASTA customers will have all test results in one, simple-to-use, smartphone application that can be shared seamlessly with organisations that require verified test results information.

Cost-effective solution to unlock the economy – COVID-19 test verification solutions are under active consideration by the UK government and multiple industries across the region to safely reopen businesses, safeguard key workers and facilitate return to work strategies. With a nominal cost of less than 20p per QR code scanned, iiPass minimises businesses’ operational risk, streamlines verification and could allow the safe, efficient restart of international travel, spectator events, corporate workplaces, and other strategic industries across the UK.

iiPass services will initially be available at eight UK MASTA test centres. The planned expansion to hundreds of pharmacies and testing centres across the UK will also reduce the strain and the potential risks of attending one of the UK’s mass rapid test centres which could become outbreak hotspots.

Gary McKay, managing director and co-founder at APPII said:

“Security and trust are at the heart of APPII’s iiPass Covid-19 app. Through our partnerships with some of the UK’s most trusted and accredited service providers, we have developed an affordable, simple, and fully verifiable testing solution, that can be used by businesses, governments, and the public alike. Our biometric identity checks make the test results in our app the safest on the market, with the possibility for fraudulent results eliminated. 

Organisations of all sizes can rest assured that the QR codes they scan in the iiPass app have been rigorously verified with leading identity technology, so cannot be copied, or passed on to multiple users. In other words, we guarantee the individual is who their QR says they are.

Our partnership with MASTA means these tests and trusted results will be available across the UK to those who need it most – from key workers to struggling industries. As we move to reinstate international travel and increase vaccination rates, our solution can also be harnessed to provide secure vaccine certification. It’s clear we will be living with this virus for years to come so there’s an urgent need for innovation and technology that facilitates the safe return to more normal daily life. At APPII, it’s our mission to be part of this solution, and to provide the systems and infrastructures that help the UK economy back on its feet, as well as getting us back to doing the things we love.”